Search results for:
interferon beta-1a
interferon beta-1a
| Drug Name |
Form |
Strength |
Notes |
| Avonex |
POWDER FOR INJECTION, INTRAMUSCULAR |
30 mcg |
|
| Rebif |
SOLUTION, SUBCUTANEOUS |
22 mcg/0.5 mL |
|
| Rebif |
SOLUTION, SUBCUTANEOUS |
44 mcg/0.5 mL |
|
Last updated: Jan. 9, 2024
This medication is Inpatient Non-formulary and Restricted to Outpatient Use. Inpatient use requires approval by a physician department leader (i.e. Medical Director or Chair, or hospital CMO) collaborating with a pharmacy leader.
See HERE for more information and workflow.
See HERE for additional pharmacy workflow details.